Change over period: —
NSE · ANURAS
ANURAS
-4.0% from the 52-week high · +23.3% above the low
Anupam Rasayan India Ltd. manufactures pharmaceutical and specialty chemical products. The company is headquartered in Surat, Gujarat. The company went IPO on 2021-03-24. The Company’s segments include Life Science Related Specialty Chemicals and Other Specialty Chemicals. The company manufactures a variety of life science related specialty chemicals comprising products related to agrochemicals, personal care, and pharmaceuticals. The firm manufactures agro intermediates and agro active ingredients for the agrochemicals industry, which are used in the manufacture of, amongst others, insecticides, fungicides, and herbicides. For the personal care industry, it provides, amongst others, anti-bacterial and ultraviolet protection intermediates, and ingredients. In the pharmaceutical segment, the Company focuses on developing intermediates and key starting materials for active pharmaceutical ingredients. The Company’s other specialty chemicals are used in diverse end-user segments, comprising specialty pigments, specialty dyes and polymer additives.
The short version. ANURAS reported revenue of ₹806 crore for Sep 2026, up 10.3% from a year earlier. Net profit was ₹50 crore (up 13.6% year on year). Return on equity was 5.1% in Mar 2026. Promoter holding was 59.07% in Sep 2026, down 2.11 points over 8 quarters.
1 · The price
How has the stock traded?
ANURAS trades 4.0% below its 52-week high and 23.3% above its 52-week low.
2 · The business
Is it growing?
Sep 2026 revenue of ₹806 cr.
Sep 2026 net profit of ₹50 cr.
0.1 pts higher than a year earlier.
Revenue compounded at 14.0% over the same 3 years.
Reported results · ₹ crore
Revenue and profit
Show the numbers
Quarterly
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 806 | 655 | 636 | 512 | 731 | 486 | 500 | 390 |
| Net profit | 50 | 39 | 43 | 49 | 44 | 34 | 45 | 28 |
| Net margin % | 6.2 | 5.9 | 6.7 | 9.6 | 6.1 | 7.0 | 8.9 | 7.2 |
| EPS (₹) | 4.39 | 3.39 | 3.75 | 4.31 | 3.9 | 3.1 | 4.05 | 2.56 |
Annual
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 2365 | 1437 | 1475 | 1602 | 1066 | 811 |
| Net profit | 170 | 93 | 129 | 181 | 152 | 70 |
| Net margin % | 7.2 | 6.5 | 8.7 | 11.3 | 14.3 | 8.7 |
| EPS (₹) | 14.94 | 8.49 | 11.71 | 16.83 | 15.18 | 7.04 |
3 · The quality
How well does it turn capital into profit?
Return on equity was 5.1% in Mar 2026; debt to equity is 0.54.
Profitability · 4 years
Returns and margins
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | |
|---|---|---|---|---|
| Return on equity % | 5.1 | 3.3 | 4.7 | 7.6 |
| Return on capital % | 7.5 | 9.0 | 10.1 | 12.4 |
| EBITDA margin % | 22.8 | 28.5 | 27.3 | 27.3 |
| Net margin % | 7.1 | 6.4 | 8.5 | 11.2 |
Compound growth
Revenue vs profit
| 3 years | 5 years | |
|---|---|---|
| Revenue CAGR | 14.0% | 23.3% |
| Profit CAGR | -2.0% | 19.3% |
4 · The owners
Who holds it, and are they adding?
Down 2.11 pts over 8 quarters.
Up 1.21 pts over 8 quarters.
Down 0.05 pts over 8 quarters.
+9 versus the previous month.
Shareholding pattern (%)
Quarter by quarter
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Change | |
|---|---|---|---|---|---|---|---|---|---|
| Promoter | 61.18 | 61.18 | 61.18 | 59.07 | 59.07 | 59.07 | 59.07 | 59.07 | -2.11 |
| FII | 7.45 | 6.46 | 4.94 | 7.63 | 7.6 | 6.91 | 7.71 | 8.66 | +1.21 |
| DII | 2.32 | 2.25 | 2.24 | 1.37 | 0.42 | 0.35 | 0.38 | 2.27 | -0.05 |
| Public | 29.05 | 30.11 | 31.65 | 31.92 | 32.9 | 33.67 | 32.83 | 30.01 | +0.96 |
Mutual fund holdings · Oct 2026
41 schemes hold this stock
32 the month before.
- ITI Mid Cap Fund1.6% of NAV
- ITI ELSS Tax Saver Fund1.3% of NAV
- Nippon India Nifty 500 Equal Weight Index Fund0.21% of NAV
- Groww Nifty Smallcap 250 Index Fund0.16% of NAV
- JioBlackRock Nifty Smallcap 250 Index Fund0.16% of NAV
- Groww Nifty Smallcap 250 ETF0.16% of NAV
- ICICI Prudential Nifty Smallcap 250 Index Fund0.16% of NAV
- Mirae Asset Nifty Smallcap 250 ETF0.16% of NAV
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for ANURAS are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Related stocks
Other Chemicals & Petrochemicals stocks
Quick answers
Common questions about ANURAS
What is the ANURAS share price?
ANURAS (ANURAS) last closed at ₹1,327.00, up 0.45% on the day. Its 52-week range is ₹1,071.80 to ₹1,376.00.
What is the market cap of ANURAS?
ANURAS has a market capitalisation of about ₹15,009 crore. Its price-to-earnings ratio is 72.4.
How are ANURAS's latest results?
ANURAS reported revenue of ₹806 crore for Sep 2026, up 10.3% from a year earlier. Net profit was ₹50 crore (up 13.6% year on year). Return on equity was 5.1% in Mar 2026. Promoter holding was 59.07% in Sep 2026, down 2.11 points over 8 quarters.
Who owns ANURAS?
As of Sep 2026, shareholding was: Promoter 59.07%, FII 8.66%, DII 2.27%, Public 30.01%.
How many mutual funds hold ANURAS?
41 mutual fund schemes held ANURAS in October 2026. That compares with 32 the month before.
Corporate actions
Recent dividends, bonuses and splits
- 21 Jul 2025 · Interim Dividend - Rs. 0.75
- 17 Sep 2024 · Final Dividend - Rs. 0.75
- 20 Nov 2023 · Interim Dividend - Rs. 0.5
- 15 May 2023 · Interim Dividend - Rs. 1.5
- 08 Feb 2023 · Interim Dividend - Rs. 0.6
- 02 Sep 2022 · Final Dividend - Rs. 1
Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.